NDC-0524 for Parkinson’s may enter clinical testing in late 2025
NDC-0524, an experimental antibody that Nitrase Therapeutics is developing as a treatment for people with Parkinson’s disease, is…
Articles by Margarida Maia, PhD
Eye test may detect early retinal changes in Parkinson’s: Study
Parkinson’s disease can lead to early retinal changes — alterations in the thin layer at the back of the…
1st look at PINK1 structure reveals Parkinson’s clues
Researchers for the first time visualized how PINK1, a protein linked to early-onset Parkinson’s disease, binds to mitochondria and…
Gut neurons may offer way to treat constipation in Parkinson’s: Study
Neurons, or nerve cells, that release a signaling molecule called glutamate within the enteric nervous system — a network of…
First Parkinson’s patient dosed in GT-02287 clinical trial
The first patient has been dosed in Gain Therapeutics‘ clinical trial of GT-02287, an investigational, oral small molecule being…
Genetic disease offers insights for Parkinson’s treatmentÂ
A rare nerve disorder may offer clues to potential Parkinson’s disease treatment targets, a mouse study showed. In giant…
Company repurposing anticancer medication RB-190 for Parkinson’s
Right Brain Bio is repurposing the approved therapy RB-190 as a treatment for Parkinson’s disease — and is…
ASAP seeks applications for $6M in Parkinson’s research grants
Note: This story was updated March 17, 2025, to correct the attribution of quotes to Sonya Dumanis, PhD, deputy director…
Phase 1 trial of cell therapy seeks more Parkinson’s patients
A small Phase 1 clinical trial testing a treatment approach that uses stem cells derived from a patient’s blood cells…
Number of people with Parkinson’s seen topping 25M by 2050: Study
The number of people with Parkinson’s disease is likely to more than double in the next years, topping 25…